Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue, net:
Core companion animal health	$ 20,757	$ 17,486	$ 40,329	$ 34,852
Other vaccines, pharmaceuticals and products	3,153	5,430	6,475	8,857
Total revenue, net	23,910	22,916	46,804	43,709
Cost of revenue	13,613	13,839	26,423	26,353
Gross profit	10,297	9,077	20,381	17,356
Operating expenses:
Selling and marketing	5,239	4,752	10,699	9,697
Research and development	392	374	811	762
General and administrative	2,837	3,034	6,021	6,081
Total operating expenses	8,468	8,160	17,531	16,540
Operating income	1,829	917	2,850	816
Interest and other expense, net	37	(7)	174	9
Income before income taxes	1,792	924	2,676	807
Income tax expense (benefit)
Current tax expense	82	32	126	53
Deferred tax expense (benefit)	532	114	789	249
Total income tax expense (benefit)	614	146	915	302
Net income	1,178	778	1,761	505
Net income (loss) attributable to non-controlling interest	(19)	(291)	(34)	(756)
Net income attributable to Heska Corporation	$ 1,197	$ 1,069	$ 1,795	$ 1,261
Basic net income per share attributable to Heska Corporation	$ 0.19	$ 0.18	$ 0.29	$ 0.21
Diluted net income per share attributable to Heska Corporation	$ 0.17	$ 0.17	$ 0.26	$ 0.20
Weighted average outstanding shares used to compute basic net income (loss) per share attributable to Heska Corp.	6,283	5,936	6,232	5,898
Weighted average outstanding shares used to compute diluted net income (loss) per share attributable to Heska Corp	7,075	6,384	6,980	6,183